• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Genesis HealthCare Announces Leadership Change

    1/5/21 8:30:00 AM ET
    $GEN
    Computer Software: Prepackaged Software
    Technology
    Get the next $GEN alert in real time by email

    George V. Hager, Jr. Retires as CEO and Director
    Board of Directors Appoints Current Chairman, Robert H. Fish as New CEO

    KENNETT SQUARE, Pa., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, announced today that George V. Hager, Jr. has decided to retire as the Company’s Chief Executive Officer (CEO) and Director. Genesis’ Board of Directors has appointed the Company’s current Chairman of the Board, Robert (“Bob”) H. Fish as CEO, effective today, January 5, 2021. Bob will remain Chairman of the Board.

    Mr. Fish, a member of the Genesis Board of Directors since 2013 and Chairman since 2017, has extensive experience as a healthcare company executive, including significant experience in the long-term care industry. Mr. Hager will continue in a senior advisory role to the Company’s Board of Directors.

    “The Board and I would like to thank George for 28 years of unwavering leadership and tireless commitment and service to the Company, its employees, patients, residents and families, and to the entire post-acute industry,” said Mr. Fish. “We are pleased that George will serve as a senior advisor to me and the Board of Directors, assisting with the transition, ongoing restructuring efforts and continued advocacy for the Company and the industry.”

    “We are fortunate to have Bob step in as a leader with significant experience both inside and outside of Genesis. He brings expertise and continuity essential to Genesis as we continue to navigate the impact of COVID-19 and explore avenues to strengthen the Company financially,” said Mr. Hager. “It has been my honor to serve and lead this Company over the last 17 years. I would like to thank the senior management team as well as our Center leaders and caregivers for their dedication and commitment to Genesis and our patients, residents and families. I am also proud to have had the opportunity to bring our founder, Michael R. Walker’s, vision to fruition these many years,” continued Mr. Hager.

    “I am pleased to become Genesis’ Chief Executive Officer and am excited to lead the Company as we look to emerge from the pandemic and navigate to recovery,” said Mr. Fish. “I look forward to sharing my vision and direction for the Company in the coming months.”

    Mr. Fish has a long history with Genesis and its predecessor companies Genesis HealthCare Corp. and Genesis Health Ventures, Inc. He has served on its current Board of Directors since 2013 when he joined Skilled Healthcare Group, Inc. as CEO until its merger with Genesis in 2015. Additionally, from 2003 to 2007, he served as Lead Director of Genesis HealthCare Corp., and from 2002 to 2003 he served as Chairman and Chief Executive Officer of Genesis Health Ventures, Inc. During his career, Mr. Fish has served as Chairman, President or CEO of several other healthcare companies. Most recently, from 2018 to July 2020, he served as President, CEO and Director of Quorum Health Corporation, a publicly held operator of general acute care hospitals and outpatient services. From 2008 to 2012, he served as Chairman of REACH Medical Holdings, a regional air medical transport company, from 2005 to 2006 he served as Executive Chairman of Coram, Inc., a large home infusion provider. Previously, Mr. Fish served as President and Chief Executive Officer of St. Joseph Health System—Sonoma County and Valleycare Health System, both regional hospital systems in Northern California.

    About Genesis HealthCare
    Genesis HealthCare is a holding company with subsidiaries that, on a combined basis, comprise one of the nation's largest post-acute care companies, providing services to more than 325 skilled nursing facilities and assisted/senior living communities in 24 states nationwide. Genesis subsidiaries also supply rehabilitation therapy to approximately 1,100 healthcare providers in 44 states, the District of Columbia and China.  References made in this release to "Genesis," "the Company," "we," "us" and "our" refer to Genesis Healthcare, Inc. and each of its wholly-owned companies. Visit our website at www.genesishcc.com.

    Genesis Healthcare Contact:
    Investor Relations
    610-925-2000


    Get the next $GEN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GEN

    DatePrice TargetRatingAnalyst
    3/18/2025Equal-Weight
    Morgan Stanley
    12/4/2024$36.00Buy
    UBS
    10/24/2024$35.00Overweight
    Wells Fargo
    6/7/2024$28.00 → $27.00Overweight → Equal-Weight
    Morgan Stanley
    4/11/2024$28.00 → $25.00Overweight → Equal Weight
    Barclays
    11/21/2023$23.00 → $26.00Equal-Weight → Overweight
    Morgan Stanley
    11/16/2023$25.00Buy
    BofA Securities
    5/19/2023$27.00Outperform
    Evercore ISI
    More analyst ratings

    $GEN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Morgan Stanley resumed coverage on Gen Digital

      Morgan Stanley resumed coverage of Gen Digital with a rating of Equal-Weight

      3/18/25 8:39:33 AM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • UBS initiated coverage on Gen Digital with a new price target

      UBS initiated coverage of Gen Digital with a rating of Buy and set a new price target of $36.00

      12/4/24 7:38:07 AM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • Wells Fargo initiated coverage on Gen Digital with a new price target

      Wells Fargo initiated coverage of Gen Digital with a rating of Overweight and set a new price target of $35.00

      10/24/24 6:32:41 AM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology

    $GEN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $GEN
    Financials

    Live finance-specific insights

    See more

    $GEN
    SEC Filings

    See more

    $GEN
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $GEN
    Leadership Updates

    Live Leadership Updates

    See more
    • CEO & President Pilette Vincent exercised 478,568 shares at a strike of $25.93 and covered exercise/tax liability with 244,119 shares, increasing direct ownership by 15% to 1,844,633 units (SEC Form 4)

      4 - Gen Digital Inc. (0000849399) (Issuer)

      5/6/25 5:16:10 PM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • CLO & Head Corp Aff Ko Bryan Seuk exercised 127,841 shares at a strike of $25.93 and covered exercise/tax liability with 67,309 shares, increasing direct ownership by 13% to 538,840 units (SEC Form 4)

      4 - Gen Digital Inc. (0000849399) (Issuer)

      5/6/25 5:15:45 PM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • CFO Derse Natalie Marie exercised 138,491 shares at a strike of $25.93 and covered exercise/tax liability with 72,917 shares, increasing direct ownership by 22% to 363,940 units (SEC Form 4)

      4 - Gen Digital Inc. (0000849399) (Issuer)

      5/6/25 5:15:20 PM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • Gen Delivers Record Q4 and Full Year Fiscal 2025 Results

      Gen raises the bar with accelerated revenue growth in FY26  TEMPE, Ariz. and PRAGUE, May 6, 2025 /PRNewswire/ -- Gen Digital Inc. (NASDAQ:GEN), a global leader dedicated to powering Digital Freedom, released its results for its fiscal year 2025 fourth quarter and full year, which ended March 28, 2025.  "Our record results and accelerated growth are driven by our mission to meet the ever-evolving needs of today's digital consumers," said Vincent Pilette, CEO of Gen. "Now with the successful acquisition of MoneyLion, we've taken the next step forward in building the most compreh

      5/6/25 4:05:00 PM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • Gen Completes Acquisition of MoneyLion, Accelerating the Company's Leadership in Financial Wellness

      TEMPE, Ariz. and PRAGUE, April 17, 2025 /PRNewswire/ -- Gen Digital Inc. (NASDAQ:GEN), a global leader dedicated to powering Digital Freedom through its family of consumer brands, today announced the successful closing of its acquisition of MoneyLion Inc. This strategic milestone strengthens Gen's leadership in financial wellness, empowering consumers to confidently manage and protect their digital and financial lives. "We're thrilled to welcome MoneyLion to the Gen family. The addition of MoneyLion accelerates our position to redefine financial empowerment in a digital-first world," said Vincent Pilette, CEO of Gen. "People need intuitive, holistic solutions th

      4/17/25 9:00:00 AM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • Gen to Announce Fiscal 2025 Fourth Quarter and Full-Year Results on May 6, 2025

      TEMPE, Ariz. and PRAGUE, April 8, 2025 /PRNewswire/ -- Gen Digital Inc. (NASDAQ:GEN) today announced that its fiscal year 2025 fourth quarter and full-year financial results will be released Tuesday, May 6, 2025, after market close. Following the press release, Gen management will host a conference call and webcast at 2 p.m. PT / 5 p.m. ET. Fiscal 2025 Q4 and Full-Year Earnings CallMay 6, 20252 p.m. PT / 5 p.m. ETConference call dial-in and live webcast link available on Investor.GenDigital.com  About GenGen™ (NASDAQ: GEN) is a global company dedicated to powering Digital Free

      4/8/25 4:05:00 PM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • Gen Digital Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Gen Digital Inc. (0000849399) (Filer)

      5/6/25 4:05:44 PM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • SEC Form S-8 POS filed by Gen Digital Inc.

      S-8 POS - Gen Digital Inc. (0000849399) (Filer)

      5/2/25 4:05:59 PM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • Gen Digital Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - Gen Digital Inc. (0000849399) (Filer)

      4/17/25 8:54:33 AM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • Gen Delivers Record Q4 and Full Year Fiscal 2025 Results

      Gen raises the bar with accelerated revenue growth in FY26  TEMPE, Ariz. and PRAGUE, May 6, 2025 /PRNewswire/ -- Gen Digital Inc. (NASDAQ:GEN), a global leader dedicated to powering Digital Freedom, released its results for its fiscal year 2025 fourth quarter and full year, which ended March 28, 2025.  "Our record results and accelerated growth are driven by our mission to meet the ever-evolving needs of today's digital consumers," said Vincent Pilette, CEO of Gen. "Now with the successful acquisition of MoneyLion, we've taken the next step forward in building the most compreh

      5/6/25 4:05:00 PM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • Edison Partners Announces Exit from MoneyLion Following Acquisition by Gen

      Third Major Exit Since Start of 2025 Leading growth equity firm Edison Partners today announced its exit from MoneyLion (NYSE:ML), following the company's acquisition by Gen Digital Inc. ("Gen") (NASDAQ:GEN), finalized on April 10. Edison Partners was MoneyLion's first institutional investor in 2016, supporting its multi-stage enterprise growth into a global fintech leader of next generation, personalized financial products. Edison has helped MoneyLion transform into a top consumer finance super app with 20 million users, and a premier content, embedded finance, and business-to-consumer financial marketplace platform. "In our persistent drive to identify profitable growth opportunities,

      4/29/25 8:00:00 AM ET
      $GEN
      $ML
      Computer Software: Prepackaged Software
      Technology
      Finance: Consumer Services
      Finance
    • Gen Completes Acquisition of MoneyLion, Accelerating the Company's Leadership in Financial Wellness

      TEMPE, Ariz. and PRAGUE, April 17, 2025 /PRNewswire/ -- Gen Digital Inc. (NASDAQ:GEN), a global leader dedicated to powering Digital Freedom through its family of consumer brands, today announced the successful closing of its acquisition of MoneyLion Inc. This strategic milestone strengthens Gen's leadership in financial wellness, empowering consumers to confidently manage and protect their digital and financial lives. "We're thrilled to welcome MoneyLion to the Gen family. The addition of MoneyLion accelerates our position to redefine financial empowerment in a digital-first world," said Vincent Pilette, CEO of Gen. "People need intuitive, holistic solutions th

      4/17/25 9:00:00 AM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • Genesis HealthCare Announces Leadership Change

      George V. Hager, Jr. Retires as CEO and DirectorBoard of Directors Appoints Current Chairman, Robert H. Fish as New CEO KENNETT SQUARE, Pa., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, announced today that George V. Hager, Jr. has decided to retire as the Company’s Chief Executive Officer (CEO) and Director. Genesis’ Board of Directors has appointed the Company’s current Chairman of the Board, Robert (“Bob”) H. Fish as CEO, effective today, January 5, 2021. Bob will remain Chairman of the Board. Mr. Fish, a member of the Genesis Board of Directors since 2013 and Cha

      1/5/21 8:30:00 AM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology